EGFR and neoplasm: Collectively, these results demonstrated that RG7388 functioned as a multifaceted anti-tumor agent against various TP53mutant NSCLC, exhibiting potent inhibition effects on proliferation and EGFR signaling pathways, as well as inductive effects on cell death.